BNTX

#526
BioNTech SE American Depositary Share
99.86 USD
+1.47%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.58
99.88
Intervallo Annuale
79.52
123.98
Variazione giornaliera
+1.47%
Variazione Mensile
+8.54%
Variazione di 6 mesi
-4.59%
Variazione Annuale
+0.95%
Chiusura Precedente
98.41
Apertura
99.59
Bid
Ask
Minimo
99.58
High
99.88
Volume
86
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q4, 25 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Notizie